Find investors
← Back to all investors
MB
ResearchedAngel Investors

Mark Benham

Managing Director

Angel InvestorsSeed Round
Pitch Mark

Get their honest, personalized take on your startup.

Sign in to pitch Mark

At a glance

Full Name
Mark R. Benham
Title
Managing Partner / Managing Director
Firm
Celerity Partners
Firm Type
Private equity firm
Investment Stage
Middle-market growth equity, buyouts, corporate divestitures, recapitalizations, and acquisition-led platform builds
Target Company Profile
U.S. and Canada companies with revenue of $10 million or more and EBITDA of $2 million to $20 million
Sector Focus
Healthcare services, contract/electronic manufacturing, energy services, infrastructure and environmental services, transportation and logistics, IT services, life sciences and healthcare
Geographic Focus
United States and Canada
Location
Redwood City / Menlo Park, California; Celerity also has Los Angeles presence

Background

Mark R. Benham is a founder and senior investment professional at Celerity Partners, a private equity firm founded in 1995. Celerity describes itself as a firm that partners with accomplished industry executives to identify, acquire, and scale market-leading “legacy enterprises” across a broad range of industries. Its current site lists Benham as Managing Partner and the point of contact for the firm.

Before co-founding Celerity, Benham worked in private equity and venture capital. A CBI profile states that from 1988 to 1992 he was a Senior Investment Officer at Citicorp Venture Capital in New York, and that before Citicorp he served as U.S. advisor to Yamaichi UniVen Co., Ltd., the venture capital unit of Yamaichi Securities International.

Benham’s public-company board history includes Live Current Media, where he became a director on September 12, 2007 and served as chair of the Compensation Committee and a member of the Audit Committee. The company’s 2009 Form 10-K says he had 15 years of private equity and investment banking experience at that time, had been a partner at Celerity since 1994, and held board roles at OnCore Manufacturing Services, Pinnacle Treatment Centers, Trigemina, Ascension Insurance, O Premium Waters, Portal Group Holdings, Verari Systems, and Peer 1 Network Enterprises.

He holds a B.A. in English from the University of California, Berkeley, and an M.A. and M.B.A. from the University of Chicago. CBI’s profile notes that the degrees were earned with honors.

Investment Thesis & Focus

  • Celerity’s stated approach is to build “legacy enterprises” through executive partnerships, disciplined capital deployment, and acquisition-led scaling rather than passive minority seed investing.
  • The firm says it conducts “proactive, proprietary research to identify emerging opportunities before they are widely recognized,” especially in fragmented markets suitable for consolidation.
  • Celerity emphasizes partnering with proven industry executives who have built and operated businesses in the target sector, then aligning incentives for long-term value creation.
  • The firm’s preferred transaction structures include growth equity, management buyouts, corporate divestitures, recapitalizations, and de-leveraging investments.
  • Public investor databases describe Celerity’s target as U.S. and Canadian companies with $2 million to $20 million of EBITDA, in sectors including healthcare services, contract manufacturing, energy services, infrastructure and environmental sciences, and transportation/logistics.
  • I found no reliable evidence that Benham is currently an active seed-stage angel investor; the verified public record points to Celerity as a middle-market private equity platform investor.

Notable Investments

  • Peer 1 Networks: Internet infrastructure and colocation company; Celerity’s site cites Peer 1 as a platform company and quotes CEO Geoff Hampson on Celerity backing management’s vision.
  • ABC Laboratories: Product development and analytical testing services provider for pharmaceutical, biotechnology, animal health, crop protection, consumer product, and chemical industries; Celerity’s site cites ABC as a portfolio company and 2009 press release notes its acquisition of Morse Laboratories.
  • All Aboard America! Holdings: Motorcoach and transportation platform; Celerity’s site cites the company as a portfolio example, and a 2015 release says AHI acquired Denver RTD as its fifth acquisition.
  • OnCore Manufacturing Services: High-complexity electronics manufacturing services provider for defense/aerospace, medical, and industrial customers; Celerity’s site and releases describe the Nu Visions / Veritek combination and OnCore rebrand.
  • Pinnacle Treatment Centers: Addiction treatment provider; listed in SEC filings and MarketScreener as a Benham board role / Celerity-linked company.
  • Verari Systems: Blade server and high-performance computing systems company; Celerity-backed company with rounds listed in venture databases and a 2006 Celerity release naming Celerity among investors.
  • eStudySite: Clinical trials research services company; listed as a Celerity investment in venture databases and as an active Benham board role by MarketScreener.
  • Well-Foam: Oilfield foam and nitrogen services provider; Celerity announced recruiting a CFO after its 2014 recapitalization, and MarketScreener lists Benham as a director.
  • Relation Insurance: Insurance brokerage firm; MarketScreener lists Benham as a director since October 19, 2021.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.